| Literature DB >> 33780532 |
Carola M C Van der Peet-Schwering1, Lisanne M G Verschuren1,2,3, Rob Bergsma2, Mette S Hedemann4, Gisabeth P Binnendijk1, Alfons J M Jansman1.
Abstract
The effects of birth weight (BiW; low BiW [LBW] vs. high BiW [HBW]) and estimated breeding value (EBV) for protein deposition (low EBV [LBV] vs. high EBV [HBV]) on N retention, N efficiency, and concentrations of metabolites in plasma and urine related to N efficiency in growing pigs were studied. At an age of 14 wk, 10 LBW-LBV (BiW: 1.07 ± 0.09 [SD] kg; EBV: -2.52 ± 3.97 g/d, compared with an average crossbred pig with a protein deposition of 165 g/d), 10 LBW-HBV (BiW: 1.02 ± 0.13 kg; EBV: 10.47 ± 4.26 g/d), 10 HBW-LBV (BiW: 1.80 ± 0.13 kg; EBV: -2.15 ± 2.28 g/d), and 10 HBW-HBV (BiW: 1.80 ± 0.15 kg; EBV: 11.18 ± 3.68 g/d) male growing pigs were allotted to the experiment. The pigs were individually housed in metabolism cages and were subjected to an N balance study in two sequential periods of 5 d, after an 11-d dietary adaptation period. Pigs were assigned to a protein adequate (A) or protein restricted (R, 70% of A) regime in a change-over design. Pigs were fed 2.8 times the energy requirements for maintenance. Nontargeted metabolomics analyses were performed in urine and blood plasma samples. The N retention (in g/d) was higher in the HBW than in the LBW pigs (P < 0.001). The N retention (in g/[kg metabolic body weight (BW0.75) · d]) and N efficiency, however, were not affected by the BiW of the pigs. The N retention (P = 0.04) and N efficiency (P = 0.04) were higher in HBV than in LVB pigs on the A regime but were not affected by EBV in pigs on the R regime. Restricting the dietary protein supply with 30% decreased the N retention (P < 0.001) but increased the N efficiency (P = 0.003). Nontargeted metabolomics showed that a hexose, free amino acids (AA), and lysophosphatidylcholines were the most important metabolites in plasma for the discrimination between HBV and LBV pigs, whereas metabolites of microbial origin contributed to the discrimination between HBV and LBV pigs in urine. This study shows that BiW does not affect N efficiency in the later life of pigs. Nitrogen efficiency and N retention were higher in HBV than in LBV pigs on the A regime but similar in HBV and LBV pigs on the R regime. In precision feeding concepts aiming to further optimize protein and AA efficiency in pigs, the variation in EBV for protein deposition of pigs should be considered as a factor determining N retention, growth performance, and N efficiency.Entities:
Keywords: birth weight; estimated breeding value for protein deposition; growing pigs; nitrogen efficiency; nitrogen retention
Year: 2021 PMID: 33780532 PMCID: PMC8188818 DOI: 10.1093/jas/skab101
Source DB: PubMed Journal: J Anim Sci ISSN: 0021-8812 Impact factor: 3.159
Composition of experimental diets (g/kg)
| Diet for the A regime | Diet for the R regime | |
|---|---|---|
| Ingredient composition, g/kg | ||
| Basal mixture1 | ||
| Wheat starch | 247.0 | 261.6 |
| Pregelatinized potato starch | 236.5 | 250.7 |
| Oat hulls | 100.0 | 105.9 |
| Dextrose | 100.0 | 105.9 |
| Beet pulp | 50.0 | 52.9 |
| Soybean oil | 31.2 | 33.1 |
| Potassium carbonate | 10.2 | 10.8 |
| Monocalcium phosphate | 11.9 | 12.6 |
| Limestone | 14.3 | 15.1 |
| Sodium chloride | 3.9 | 4.1 |
| Vitamin and mineral premix2 | 5.0 | 5.3 |
| Titanium dioxide | 4.0 | 4.0 |
| Protein-containing ingredients | ||
| Casein | 52.0 | 38.6 |
| Wheat gluten meal | 94.9 | 70.4 |
| Potato protein3 | 37.2 | 27.6 |
| | 1.7 | 1.3 |
| | 0.2 | 0.1 |
| Analyzed composition, g/kg | ||
| DM | 901 | 901 |
| Crude ash | 50.1 | 52.2 |
| Crude protein (N × 6.25) | 165.8 | 125.4 |
| Crude fat | 24.5 | 24.8 |
| Starch | 420.4 | 438.1 |
| Sugar | 93.8 | 103.8 |
| Titanium | 2.59 | 2.71 |
| GE, MJ/kg | 16.71 | 16.53 |
| NE, MJ/kg4 | 10.58 | 10.62 |
| AID lysine4 | 8.5 | 6.4 |
| AID methionine + cystine4 | 5.4 | 4.1 |
| AID threonine4 | 5.6 | 4.2 |
| AID tryptophan4 | 1.6 | 1.2 |
| AID isoleucine4 | 6.7 | 5.0 |
1Two levels of dietary protein supply, A or R (70% of A), were used in the study, at a similar daily supply of other nutrients. In the R supply, the proportion of protein-containing ingredients in the diet was reduced by 30% relative to the proportion in the A diet. In order to supply all pigs, relative to their metabolic BW, with the same amount of basal ingredients and nutrients, the feed allowance of pigs on the R regime was 94.4% of that of the A regime.
2Provided per kilogram of adequate protein diet: vitamin A, 7,000 IU; vitamin D3, 1,700 IU; vitamin E, 100 IU; vitamin K3, 1.5 mg; thiamine, 0.75 mg; riboflavin, 5.0 mg; d-pantothenic acid, 11 mg; niacin, 60 mg; vitamin B12, 18 μg; folic acid, 2.5 mg; pyridoxine, 1.0 mg; choline chloride, 100 mg; Fe (FeSO4–H2O), 75 mg; Cu (CuSO4–5H2O), 10 mg; Zn (ZnSO4–H2O), 65 mg; Mn (MnO), 30 mg; I (KI), 0.75 mg; and Se (Na2SeO3–5H2O), 0.3 mg.
3Protastar, Avebe Feed, Veendam, The Netherlands.
4NE and apparent ileal digestible (AID) lysine based on CVB (2016) feed table. Chemical composition and nutritional value of feedstuffs.
BW development1 (kg) of male growing pigs with an LBW or HBW and an LBV or HBV for protein deposition
| BiW | EBV |
| |||||||
|---|---|---|---|---|---|---|---|---|---|
| LBW | HBW | SEM | LBV | HBV | SEM | BiW | EBV | BiW × EBV | |
| Birth | 1.04 | 1.80 | 0.03 | 1.41 | 1.43 | 0.03 | <0.001 | 0.53 | 0.58 |
| Day 28 | 6.58 | 8.79 | 0.24 | 7.59 | 7.72 | 0.24 | <0.001 | 0.71 | 0.95 |
| Day 63 | 19.4 | 26.1 | 0.48 | 22.6 | 22.8 | 0.48 | <0.001 | 0.77 | 0.47 |
| Day 98 | 49.0 | 59.9 | 0.92 | 54.5 | 54.6 | 0.92 | <0.001 | 0.81 | 0.41 |
| Day 104 | 53.2 | 62.7 | 1.09 | 58.0 | 57.9 | 1.09 | <0.001 | 0.97 | 0.33 |
| Day 114 | 60.6 | 70.5 | 1.33 | 65.8 | 65.3 | 1.33 | <0.001 | 0.80 | 0.38 |
| Day 125 | 69.8 | 83.3 | 1.30 | 77.0 | 76.1 | 1.30 | <0.001 | 0.62 | 0.21 |
1BW of the pigs was determined at birth, day 28 (weaning), day 63 (moving to the GF room), day 98 (start N balance study), days 104 and 114 (start of both periods of adaptation to the experimental diets), and day 125 (end of the experimental period).
Effects of BiW, EBV for protein deposition, and dietary protein supply on nitrogen (N) balance parameters (g/[kg BW0.75 · d]) in male growing pigs
| BiW1 | EBV1 | Dietary protein supply1 |
| |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| LBW | HBW | SEM | LBV | HBV | SEM | A | R | SEM | BiW | EBV | Diet | |
| N intake | 1.906 | 1.909 | 0.009 | 1.908 | 1.907 | 0.009 | 2.201 | 1.614 | 0.008 | 0.78 | 0.91 | <0.001 |
| Fecal N | 0.171 | 0.159 | 0.005 | 0.168 | 0.162 | 0.005 | 0.160 | 0.169 | 0.004 | 0.12 | 0.48 | 0.16 |
| Urinary N2 | 0.694 | 0.731 | 0.019 | 0.743 | 0.682 | 0.019 | 0.882 | 0.543 | 0.014 | 0.19 | 0.03 | <0.001 |
| N retention3 | 1.041 | 1.020 | 0.022 | 0.998 | 1.063 | 0.022 | 1.159 | 0.902 | 0.016 | 0.51 | 0.04 | <0.001 |
| N efficiency4,5, % | 54.8 | 53.7 | 1.03 | 52.7 | 55.8 | 1.03 | 52.7 | 55.8 | 0.67 | 0.42 | 0.04 | 0.003 |
| N efficiency6,7 | 60.8 | 59.0 | 1.05 | 58.4 | 61.5 | 1.05 | 57.2 | 62.7 | 0.71 | 0.23 | 0.04 | <0.001 |
1Number of observations: 36 and 37 in LBW and HBW pigs, respectively; 36 and 37 in LBV and HBV pigs, respectively; 36 and 37 on the A and R regime, respectively.
2An EBV × Diet interaction was observed (P = 0.006): A regime: urinary N in pigs with LBV and HBV is 0.942 and 0.822 g/(kg BW0.75 · D), respectively; R regime: urinary N in pigs with LBV and HBV is 0.544 and 0.542 g/(kg BW0.75 · d), respectively.
3An EBV × Diet interaction was observed (P = 0.05): A regime: N retention in pigs with LBV and HBV is 1.104 and 1.214 g/(kg BW0.75 · d), respectively; R regime: N retention in pigs with LBV and HBV is 0.892 and 0.912 g/(kg BW0.75 · d), respectively.
4N efficiency = 100% × N retention/N intake.
5An EBV × Diet interaction was observed (P = 0.04): A regime: N efficiency in pigs with LBV and HBV is 50.2% and 55.2%, respectively; R regime: N efficiency in pigs with LBV and HBV is 55.2% and 56.3%, respectively.
6N efficiency = 100% × N retention / fecal digestible N intake.
7An EBV × Diet interaction was observed (P = 0.02): A regime: N efficiency in pigs with LBV and HBV is 54.4% and 60.0%, respectively; R regime: N efficiency in pigs with LBV and HBV is 62.3% and 63.0%, respectively.
Effects of BiW, EBV for protein deposition, and dietary protein supply on total tract digestibility of dry matter (DM), nitrogen (N), and gross energy (GE) (%) in male growing pigs
| BiW1 | EBV1 | Dietary protein supply1 |
| |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| LBW | HBW | SEM | LBV | HBV | SEM | A | R | SEM | BiW | EBV | Diet | |
| DM | 88.0 | 88.3 | 0.15 | 88.0 | 88.3 | 0.15 | 88.7 | 87.6 | 0.17 | 0.14 | 0.28 | <0.001 |
| N | 90.8 | 91.5 | 0.29 | 91.0 | 91.3 | 0.29 | 92.7 | 89.5 | 0.22 | 0.12 | 0.43 | <0.001 |
| GE | 88.2 | 88.8 | 0.23 | 88.4 | 88.5 | 0.23 | 89.1 | 87.9 | 0.19 | 0.07 | 0.77 | <0.001 |
1Number of observations: 36 and 37 in LBW and HBW pigs, respectively; 36 and 37 in LBV and HBV pigs, respectively; 36 and 37 on the A and R regime, respectively.
Effects of BiW, EBV for protein deposition, and dietary protein supply on the concentration of nitrogen, urea, and creatinine in the urine of male growing pigs
| BiW1 | EBV1 | Dietary protein supply1 |
| |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| LBW | HBW | SEM | LBV | HBV | SEM | A | R | SEM | BiW | EBV | Diet | |
| Nitrogen, g/kg | 4.24 | 3.61 | 0.28 | 3.91 | 3.93 | 0.28 | 4.78 | 3.07 | 0.15 | 0.11 | 0.96 | <0.001 |
| Urea, mmol/L | 117.3 | 99.3 | 7.4 | 108.4 | 108.2 | 7.4 | 135.5 | 81.1 | 4.5 | 0.10 | 0.98 | <0.001 |
| Creatinine, mmol/L | 7.05 | 6.39 | 0.45 | 6.27 | 7.17 | 0.45 | 6.65 | 6.79 | 0.25 | 0.31 | 0.17 | 0.70 |
1Number of observations: 36 and 37 in LBW and HBW pigs, respectively; 36 and 37 in LBV and HBV pigs, respectively; 36 and 37 on the A and R regime, respectively.
Effects of BiW, EBV for protein deposition, and dietary protein supply on the concentration of insulin, glucose, urea, IGF-1, α amino nitrogen (N), and creatinine in the blood plasma of male growing pigs
| BiW1 | EBV1 | Dietary protein supply1 |
| |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| LBW | HBW | SEM | LBV | HBV | SEM | A | R | SEM | BiW | EBV | Diet | |
| Insulin, uU/mL | 28.6 | 31.8 | 2.26 | 31.0 | 29.4 | 2.26 | 32.5 | 27.9 | 1.68 | 0.32 | 0.63 | 0.06 |
| Glucose, mmol/L | 6.43 | 5.90 | 0.13 | 6.02 | 6.31 | 0.13 | 6.24 | 6.10 | 0.09 | 0.007 | 0.13 | 0.29 |
| Urea, mmol/L | 3.19 | 3.12 | 0.10 | 3.21 | 3.10 | 0.10 | 3.67 | 2.64 | 0.06 | 0.65 | 0.41 | <0.001 |
| IGF-12,3, µg/L | 184 | 195 | 10.6 | 182 | 197 | 10.6 | 200 | 179 | 3.7 | 0.46 | 0.32 | <0.001 |
| α amino N, mmol/L | 7.37 | 7.37 | 0.14 | 7.45 | 7.29 | 0.14 | 7.36 | 7.38 | 0.11 | 1.00 | 0.42 | 0.88 |
| Creatinine, µmol/L | 95.7 | 96.2 | 2.4 | 90.3 | 101.5 | 2.4 | 91.0 | 100.8 | 1.7 | 0.88 | 0.002 | <0.001 |
1Number of observations: 36 and 37 in LBW and HBW pigs, respectively; 36 and 37 in LBV and HBV pigs, respectively; 36 and 37 on the A and R regime, respectively.
2A BiW × Diet interaction was observed (P = 0.02): A regime: IGF-1 in pigs with LBW and HBW is 200 and 199 µg/L, respectively; R regime: IGF-1 in pigs with LBW and HBW is 167 and 191 µg/L, respectively.
3An EBV × Diet interaction was observed (P = 0.02): A regime: IGF-1 in pigs with LBV and HBV is 186 and 214 µg/L, respectively; R regime: IGF-1 in pigs with LBV and HBV is 178 and 180 µg/L, respectively.
Models used in PLS-DA of the metabolome profiles in plasma and urine
| Model | No. of observations | No. of observations after outlier removal | Initial feature no. | Final feature no. | PC no. | evY1calibrated | evY validated |
|
|---|---|---|---|---|---|---|---|---|
| EBV | ||||||||
| Urine negative | 78 | 72 | 2,374 | 414 | 5 | 88.4 | 56.9 | 0.557 |
| Urine positive | 78 | 75 | 4,302 | 823 | 5 | 86.8 | 59.1 | 0.578 |
| Plasma negative | 78 | 194 | 1 | 33.7 | −28.0 | −0.022 | ||
| Plasma positive | 67 | 65 | 482 | 63 | 4 | 60.0 | 29.8 | 0.311 |
| Dietary protein supply | ||||||||
| Urine negative | 78 | 72 | 2,374 | 426 | 3 | 82.4 | 64.9 | 0.639 |
| Urine positive | 78 | 73 | 4,302 | 842 | 3 | 82.8 | 65.4 | 0.646 |
| Plasma negative | 78 | 78 | 194 | 33 | 3 | 64.4 | 51.2 | 0.502 |
| Plasma positive | 67 | 65 | 482 | 61 | 4 | 76.5 | 56.0 | 0.558 |
1Explained variation in Y.
Figure 1.PC plot of plasma samples in positive mode (A), urine samples in positive mode (B), and urine samples in negative mode (C). Colors indicate the different EBV for protein deposition of the pigs.
List of plasma and urine metabolites identified from metabolomics analysis discriminating between male growing pigs differing in EBV for protein deposition1
| Metabolite | Adduct | Mode2 | RT | M to Z ratio | VIP | Level of ID3 | Fold change4 |
| |||
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | EBV | D | EBV | D × EBV | |||||||
| Plasma | |||||||||||
| LPC 16:0 | [M + H]+ | Pos | 9.64 | 496.341 | 6.57 | 3 | −1.07 | 1.02 | 0.50 | 0.47 | 0.80 |
| Leucine | [Fragment] | Pos | 1.23 | 86.097 | 5.65 | 1 | −1.12 | −1.01 | 0.01 | 0.56 | 0.27 |
| Phenylalanine | [Fragment] | Pos | 2.11 | 120.081 | 5.03 | 1 | −1.09 | −1.04 | 0.05 | 0.02 | 0.25 |
| LPC 18:2 | [M + H]+ | Pos | 9.21 | 520.341 | 3.92 | 2 | 1.04 | 1.06 | 0.89 | 0.10 | 0.83 |
| Phenylalanine | [M + H]+ | Pos | 2.11 | 166.087 | 3.46 | 1 | −1.09 | −1.04 | 0.05 | 0.01 | 0.24 |
| LPC 18:0 | [M + H]+ | Pos | 10.96 | 524.372 | 3.41 | 3 | −1.02 | 1.08 | 0.73 | 0.30 | 0.45 |
| Leucine | [M + H]+ | Pos | 1.25 | 132.102 | 3.11 | 1 | −1.12 | −1.01 | 0.004 | 0.52 | 0.19 |
| LPC 18:1 | [M + H]+ | Pos | 9.98 | 522.357 | 2.65 | 2 | 1.01 | 1.08 | 0.76 | 0.23 | 0.45 |
| Creatinine | [M + H]+ | Pos | 0.70 | 114.066 | 2.60 | 1 | 1.09 | −1.11 | 0.002 | 0.14 | 0.46 |
| C6H12O6 | [M + Na]+ | Pos | 0.70 | 203.053 | 2.54 | 3 | −1.00 | −1.05 | 0.83 | 0.04 | 0.85 |
| C6H12O6 | [2M + Na]+ | Pos | 0.70 | 383.117 | 1.01 | 3 | 1.00 | −1.07 | 0.83 | 0.02 | 0.67 |
| Methionine | [M+ H ]+ | Pos | 0.94 | 150.059 | 0.41 | 1 | −1.09 | −1.07 | 0.03 | 0.01 | 0.07 |
| Phenylalanine | [Fragment] | Pos | 2.11 | 103.055 | 0.32 | 1 | −1.10 | −1.04 | 0.06 | 0.02 | 0.29 |
| Urine | |||||||||||
| | [M − H]− | Neg | 4.01 | 283.082 | 13.57 | 2 | 1.06 | −1.08 | 0.38 | 0.08 | 0.80 |
| 2-Methylbutyrylglycine/valerylglycine | [M − H]− | Neg | 3.00 | 158.082 | 12.42 | 2 | −1.11 | 1.17 | 0.90 | 0.34 | 0.15 |
| Phenylacetylglycine | [M − H]− | Neg | 3.85 | 192.066 | 11.64 | 1 | 1.04 | −1.08 | 0.46 | 0.25 | 0.62 |
| Citric acid | [M − H]− | Neg | 0.94 | 191.020 | 11.60 | 1 | −1.17 | 1.02 | 0.60 | 0.86 | 0.79 |
| Hippuric acid | [M − H]− | Neg | 3.51 | 178.051 | 9.90 | 1 | 1.02 | −1.07 | 0.43 | 0.43 | 0.39 |
| | [M − H]− | Neg | 4.04 | 187.007 | 8.26 | 1 | 1.04 | −1.09 | 0.79 | 0.09 | 0.60 |
| Sulfated steroid | [M − H]− | Neg | 6.24 | 367.158 | 8.21 | 3 | 1.04 | −1.22 | 0.76 | 0.57 | 0.43 |
| Sulfated compound | [M − H]− | Neg | 3.57 | 167.038 | 7.02 | 3 | 1.11 | 1.08 | 0.63 | 0.96 | 0.93 |
| Glucuronide conjugate | [M − H]− | Neg | 5.81 | 415.197 | 6.43 | 3 | 1.08 | −1.03 | 0.80 | 0.12 | 0.46 |
| Glucuronide conjugate | [M − H]− | Neg | 4.26 | 449.202 | 6.42 | 3 | 1.06 | −1.16 | 0.33 | 0.11 | 0.93 |
| Glucuronide conjugate | [M − H]− | Neg | 5.26 | 433.208 | 5.49 | 3 | 1.00 | −1.32 | 0.99 | 0.001 | 0.76 |
| Glucuronide conjugate | [M − H]− | Neg | 4.97 | 431.192 | 5.05 | 3 | 1.02 | −1.25 | 0.85 | 0.01 | 0.34 |
| Glucuronide conjugate | [M − H]− | Neg | 6.12 | 461.239 | 3.00 | 3 | 1.11 | −1.50 | 0.97 | 0.0002 | 0.82 |
| Glucuronide conjugate | [M − H]− | Neg | 6.26 | 417.213 | 2.32 | 3 | 1.16 | −1.21 | 0.49 | 0.01 | 0.59 |
| Phenylacetylglycine | [M + H]+ | Pos | 3.86 | 194.081 | 40.04 | 1 | −1.01 | −1.05 | 0.26 | 0.39 | 0.18 |
| 2-Methylbutyrylglycine/valerylglycine | [M + H]+ | Pos | 3.00 | 160.097 | 15.23 | 2 | −1.11 | 1.18 | 0.76 | 0.47 | 0.12 |
| Hippuric acid | [Fragment] | Pos | 3.50 | 105.034 | 14.92 | 1 | 1.04 | −1.07 | 0.30 | 0.48 | 0.31 |
| Hippuric acid | [M + H]+ | Pos | 3.50 | 180.066 | 14.70 | 1 | 1.05 | −1.06 | 0.28 | 0.53 | 0.27 |
| Creatinine | [M + H]+ | Pos | 0.72 | 114.066 | 12.50 | 1 | 1.00 | −1.13 | 0.85 | 0.12 | 0.34 |
| Cinnamoylglycine | [Fragment] | Pos | 4.77 | 131.049 | 9.26 | 1 | 1.16 | 1.53 | 0.63 | 0.80 | 0.89 |
| Unidentified | [M + H]+ | Pos | 4.96 | 510.272 | 9.25 | 4 | 1.063 | −1.12 | 0.97 | 0.65 | 0.38 |
| Unidentified | [M + H]+ | Pos | 5.37 | 130.065 | 9.24 | 4 | −1.13 | 1.00 | 0.72 | 0.34 | 0.81 |
| Piperidine | [M + H]+ | Pos | 0.83 | 86.097 | 8.05 | 1 | 1.14 | −1.44 | 0.08 | 0.22 | 0.25 |
| | [Fragment] | Pos | 3.93 | 144.045 | 7.38 | 2 | −1.02 | 1.07 | 0.87 | 0.50 | 0.64 |
| Creatinine | [M + Na]+ | Pos | 0.70 | 136.048 | 5.36 | 1 | 1.11 | −1.30 | 0.94 | 0.02 | 0.09 |
| Unidentified | [M + H]+ | Pos | 5.34 | 444.312 | 3.81 | 4 | −1.18 | −1.40 | 0.25 | 0.01 | 0.91 |
| Unidentified | [M + H]+ | Pos | 5.95 | 635.379 | 3.58 | 4 | −1.48 | −1.87 | 0.01 | 0.001 | 0.40 |
| Creatinine | [2M + Na]+ | Pos | 0.70 | 249.107 | 3.50 | 1 | 1.18 | −1.42 | 0.70 | 0.01 | 0.15 |
| Melatonin glucuronide | [M + H]+ | Pos | 3.82 | 409.160 | 3.23 | 2 | −1.01 | −1.45 | 0.99 | 0.01 | 0.84 |
| 7-Methylguanine | [M + H]+ | Pos | 0.90 | 166.072 | 2.76 | 2 | 1.10 | −1.16 | 0.45 | 0.02 | 1.00 |
| Unidentified | [M + H]+ | Pos | 5.95 | 307.202 | 2.52 | 4 | −1.42 | −1.63 | 0.02 | 0.001 | 0.47 |
1The table encompasses the 10 metabolites with the highest VIP scores in each sample type and ionization mode and metabolites differing significantly between HBV and LBV.
2Pos, positive; Neg, negative.
3Level of identification: (ID): identified metabolites (level 1), putatively annotated compounds (level 2), putatively characterized compound classes (level 3), and unknown compounds (level 4).
4Fold change in metabolite intensity: dietary protein supply (D: A [reference] vs. R regime) and EBV (high [reference] vs. low).
5 P-values for the main effects of dietary protein supply (D: A or R regime [70% of A]), EBV, and the interactive effect of dietary protein supply and EBV (D × EBV).
List of plasma and urine metabolites identified from metabolomics analysis discriminating between male growing pigs that were fed according to A or R regime1
| Metabolite | Adduct | Mode2 | RT | M to Z ratio | VIP | Level of ID3 | Fold change4 |
| |||
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | EBV | D | EBV | D × EBV | |||||||
| Plasma | |||||||||||
| Tyrosine6 | [M − H]− | Neg | 1.16 | 180.067 | 5.32 | 1 | −1.19 | 1.01 | 0.001 | 0.43 | 0.24 |
| Lactic acid | [M − H]− | Neg | 0.97 | 89.024 | 4.08 | 1 | 1.03 | 1.02 | 0.98 | 0.43 | 0.37 |
| Indoxylsulfuric acid | [M − H]− | Neg | 3.54 | 212.002 | 3.71 | 1 | −1.63 | 1.23 | 0.12 | 0.21 | 0.91 |
| Tryptophan | [M − H]− | Neg | 2.88 | 203.083 | 3.40 | 1 | −1.17 | 1.04 | 0.01 | 0.68 | 0.77 |
| Phenylalanine6 | [M − H]− | Neg | 2.11 | 164.072 | 1.78 | 1 | −1.16 | −1.02 | 0.002 | 0.05 | 0.61 |
| Leucine | [M − H]− | Neg | 1.27 | 130.087 | 1.73 | 1 | −1.18 | 1.01 | 0.0001 | 0.31 | 0.32 |
| Ketoisoleucine | [M − H]− | Neg | 3.21 | 129.056 | 1.54 | 1 | −1.13 | −1.08 | 0.002 | 0.53 | 0.68 |
| Taurodeoxycholic acid | [M − H]− | Neg | 5.87 | 498.290 | 1.22 | 2 | −2.20 | 1.09 | 0.004 | 0.47 | 0.92 |
| Ketoleucine | [M − H]− | Neg | 3.54 | 129.056 | 1.21 | 1 | −1.03 | 1.06 | 0.09 | 0.54 | 0.22 |
| Unidentified | [M − H]− | Neg | 0.71 | 215.033 | 0.98 | 4 | −1.05 | −1.04 | 0.11 | 0.11 | 0.93 |
| Azelaic acid | [M − H]− | Neg | 4.90 | 187.098 | 0.60 | 1 | 1.12 | −1.02 | 0.001 | 0.43 | 0.51 |
| 2-Hydroxybutyric acid | [M − H]− | Neg | 1.56 | 103.040 | 0.54 | 1 | −1.41 | −1.07 | 0.01 | 0.76 | 0.77 |
| Hydroxyphenyllactic acid6 | [M − H]− | Neg | 2.92 | 181.051 | 0.35 | 1 | −1.21 | −1.13 | 0.002 | 0.16 | 0.77 |
| Tyrosine6 | [2M + Na]− | Neg | 1.15 | 383.122 | 0.34 | 1 | −1.20 | 1.03 | 0.01 | 0.55 | 0.31 |
| Unidentified | [M − H]− | Neg | 1.17 | 189.041 | 0.25 | 4 | 1.14 | −1.11 | 0.001 | 0.87 | 0.37 |
| Indolelactic acid | [M − H]− | Neg | 4.61 | 204.067 | 0.19 | 2 | −1.19 | −1.07 | 0.03 | 0.88 | 0.68 |
| 4-Trimethylammonio-butanoic acid | [Fragment] | Pos | 2.57 | 100.112 | 5.79 | 2 | 1.30 | 1.01 | 0.001 | 0.98 | 0.06 |
| Leucine | [Fragment] | Pos | 1.23 | 86.097 | 5.10 | 1 | −1.12 | −1.00 | 0.005 | 0.57 | 0.54 |
| LPC 18:2 | [M + H]+ | Pos | 9.21 | 520.341 | 3.27 | 2 | 1.01 | 1.03 | 0.88 | 0.32 | 0.74 |
| Phenylalanine | [Fragment] | Pos | 2.11 | 120.081 | 2.68 | 1 | −1.10 | −1.05 | 0.05 | 0.01 | 0.49 |
| Leucine | [M + H]+ | Pos | 1.25 | 132.102 | 2.64 | 1 | −1.12 | −1.00 | 0.004 | 0.53 | 0.38 |
| 4-Trimethylammonio-butanoic acid | [M + H]+ | Pos | 2.57 | 146.118 | 2.59 | 2 | 1.31 | 1.02 | 0.003 | 0.94 | 0.04 |
| Unidentified | [M + H]+ | Pos | 4.58 | 239.090 | 2.53 | 4 | −1.00 | −1.00 | 0.31 | 0.82 | 0.14 |
| Creatine | [M + H]+ | Pos | 0.71 | 132.077 | 2.22 | 1 | −1.12 | 1.09 | 0.78 | 0.55 | 0.86 |
| LPC 16:0 | [M + H]+ | Pos | 9.64 | 496.341 | 2.21 | 3 | −1.10 | −1.00 | 0.42 | 0.76 | 0.98 |
| Tryptophan | [Fragment] | Pos | 2.87 | 188.071 | 2.17 | 1 | −1.17 | 1.01 | 0.16 | 0.65 | 0.67 |
| Valine6 | [M + Na]+ | Pos | 0.82 | 72.081 | 1.98 | 1 | −1.17 | −1.01 | 0.001 | 0.86 | 0.62 |
| Proline | [M + H]+ | Pos | 0.73 | 116.071 | 1.54 | 1 | −1.16 | 1.01 | 0.05 | 0.57 | 0.88 |
| Tyrosine | [M + H]+ | Pos | 1.14 | 182.082 | 1.19 | 1 | −1.14 | −1.03 | 0.03 | 0.45 | 0.28 |
| Creatinine | [M + H]+ | Pos | 0.70 | 114.066 | 0.97 | 1 | 1.09 | −1.11 | 0.002 | 0.15 | 0.58 |
| Urea6 | [M + H]+ | Pos | 0.71 | 61.040 | 0.95 | 1 | −1.21 | 1.04 | 0.05 | 0.47 | 0.86 |
| Tyrosine | [Fragment] | Pos | 1.14 | 165.055 | 0.95 | 1 | −1.14 | −1.03 | 0.03 | 0.47 | 0.29 |
| Urine | |||||||||||
| Citric acid6 | [M − H]− | Neg | 0.94 | 191.020 | 24.45 | 1 | −1.11 | 1.04 | 0.86 | 0.98 | 0.73 |
| | [M − H]− | Neg | 4.01 | 283.082 | 16.86 | 2 | 1.06 | −1.08 | 0.38 | 0.08 | 0.80 |
| Phenylacetylglycine6 | [M − H]− | Neg | 3.85 | 192.066 | 15.32 | 1 | 1.04 | −1.08 | 0.46 | 0.25 | 0.62 |
| Hippuric acid6 | [M − H]− | Neg | 3.51 | 178.051 | 13.50 | 1 | 1.02 | −1.07 | 0.43 | 0.43 | 0.39 |
| 2-Methylbutyrylglycine/valerylglycine6 | [M − H]− | Neg | 3.00 | 158.082 | 13.47 | 2 | −1.11 | 1.17 | 0.90 | 0.34 | 0.15 |
| Indoxylsulfuric acid | [M − H]− | Neg | 3.46 | 212.002 | 11.59 | 1 | 1.04 | −1.13 | 0.66 | 0.37 | 0.85 |
| Hydroxyphenyllactic acid1 | [M − H]− | Neg | 2.89 | 181.051 | 8.13 | 1 | −1.20 | −1.12 | 0.09 | 0.03 | 0.75 |
| Citric acid6 | [Fragment] | Neg | 0.94 | 111.009 | 7.67 | 1 | −1.17 | 1.02 | 0.60 | 0.86 | 0.79 |
| | [M − H]− | Neg | 4.04 | 187.007 | 7.10 | 1 | 1.04 | −1.09 | 0.79 | 0.09 | 0.60 |
| | [2M − H]− | Neg | 4.00 | 567.171 | 6.72 | 2 | 1.10 | −1.12 | 0.46 | 0.08 | 0.89 |
| Taurine | [M − H]− | Neg | 0.68 | 124.007 | 4.53 | 1 | −2.36 | 1.33 | 0.0002 | 0.01 | 0.01 |
| Sulfated compound | [M − H]− | Neg | 5.61 | 303.127 | 4.41 | 3 | −1.35 | −1.32 | 0.02 | 0.01 | 0.53 |
| Acetyl- | [M − H]− | Neg | 3.75 | 172.098 | 2.87 | 1 | −1.31 | 1.01 | 0.03 | 0.85 | 0.98 |
| Unidentified | [M − H]− | Neg | 5.28 | 309.134 | 2.41 | 4 | −1.62 | −1.23 | 0.01 | 0.09 | 0.56 |
| Phenylacetylglycine6 | [M + H]+ | Pos | 3.86 | 194.081 | 22.54 | 1 | 1.02 | −1.11 | 0.44 | 0.24 | 0.49 |
| Hippuric acid6 | [Fragment] | Pos | 3.50 | 105.034 | 13.75 | 1 | 1.02 | −1.08 | 0.40 | 0.41 | 0.46 |
| Glucoronidated compound | [M + H]+ | Pos | 4.00 | 302.124 | 12.68 | 3 | −1.32 | 1.08 | 0.36 | 0.68 | 0.22 |
| Creatinine6 | [M + H]+ | Pos | 0.72 | 114.066 | 12.58 | 1 | 1.02 | −1.17 | 0.88 | 0.06 | 0.69 |
| Hippuric acid6 | [M + H]+ | Pos | 3.50 | 180.066 | 12.28 | 1 | 1.02 | −1.07 | 0.38 | 0.45 | 0.43 |
| 7-Methylguanine | [M + H]+ | Pos | 0.90 | 166.072 | 6.62 | 2 | 1.12 | −1.22 | 0.75 | 0.01 | 0.42 |
| Picolinoylglycine | [M + H]+ | Pos | 2.98 | 181.061 | 6.09 | 2 | −1.57 | −1.33 | 0.02 | 0.05 | 0.86 |
| 2-Methylbutyrylglycine/valerylglycine6 | [M + H]+ | Pos | 3.00 | 160.097 | 5.62 | 2 | −1.14 | 1.20 | 0.81 | 0.49 | 0.17 |
| Unidentified | [M + H]+ | Pos | 5.95 | 307.202 | 5.55 | 4 | −1.42 | −1.67 | 0.02 | 0.001 | 0.39 |
| Creatinine6 | [M + K]+ | Pos | 0.71 | 152.022 | 5.44 | 1 | 1.15 | −1.27 | 0.08 | 0.04 | 0.95 |
| Oxindole | [M + H]+ | Pos | 3.43 | 134.060 | 4.21 | 2 | 1.19 | −1.17 | 0.03 | 0.69 | 0.49 |
| Unidentified | [M + H]+ | Pos | 3.17 | 288.181 | 3.90 | 4 | −1.34 | −1.05 | 0.01 | 0.01 | 0.49 |
1The table encompasses the 10 metabolites with the highest VIP scores in each sample type and ionization mode and metabolites differing significantly between male growing pigs that were fed according to the A or R regime.
2Pos, positive; Neg, negative.
3Level of identification: identified metabolites (level 1), putatively annotated compounds (level 2), putatively characterized compound classes (level 3), and unknown compounds (level 4).
4Fold change in metabolite intensity: dietary protein supply (D: A [reference] vs. R regime) and EBV (high [reference] vs. low).
5 P-values for the main effects of dietary protein supply (D: A or R regime [R, 70% of A]), EBV, and the interactive effect of dietary protein supply and EBV (D × EBV).
6Metabolites also identified in our previous experiment (Van der Peet-Schwering et al. (2020).